{
     "PMID": "25058044",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141217",
     "LR": "20141011",
     "IS": "1090-2430 (Electronic) 0014-4886 (Linking)",
     "VI": "261",
     "DP": "2014 Nov",
     "TI": "l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors.",
     "PG": "377-85",
     "LID": "10.1016/j.expneurol.2014.07.006 [doi] S0014-4886(14)00234-9 [pii]",
     "AB": "Parkinson's disease (PD) patients exhibit motor and non-motor symptoms that severely affect quality of life. Cognitive alterations in PD subjects have been related to both structural and functional hippocampal changes. Here we investigated the effects of the 6-hydroxydopamine (6-OHDA) lesion in the Medial Forebrain Bundle (MFB) on the hippocampus focusing on the Dentate Gyrus (DG). In vivo microdialysis measurements revealed that the 6-OHDA injection disrupts both dopaminergic and noradrenergic transmission in rat DG. In vitro electrophysiological recordings showed that these neurochemical alterations were accompanied by impairment of long-term depression (LTD) at medial perforant path/DG synapses. Furthermore, this alteration was reversed by l-DOPA treatment. Notably, the therapeutic effect of l-DOPA on LTD was blocked by the antagonism of beta-noradrenergic receptors, but not by dopamine D1 or D2 receptor antagonists. Thus, while the dopaminergic transmission does not seem to be implicated in this therapeutic effect of l-DOPA, the noradrenergic system plays a central role in the synaptic dysfunction of the DG in experimental PD. Our work provides new evidence on the role of catecholamines in DG synaptic plasticity and sheds light on the possible synaptic mechanisms underlying cognitive deficits in PD. Furthermore, our results indicate that l-DOPA exerts a therapeutic effect on the parkinsonian brain through different, coexistent, mechanisms.",
     "CI": [
          "Copyright (c) 2014 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Pendolino, Valentina",
          "Bagetta, Vincenza",
          "Ghiglieri, Veronica",
          "Sgobio, Carmelo",
          "Morelli, Emanuela",
          "Poggini, Silvia",
          "Branchi, Igor",
          "Latagliata, Emanuele C",
          "Pascucci, Tiziana",
          "Puglisi-Allegra, Stefano",
          "Calabresi, Paolo",
          "Picconi, Barbara"
     ],
     "AU": [
          "Pendolino V",
          "Bagetta V",
          "Ghiglieri V",
          "Sgobio C",
          "Morelli E",
          "Poggini S",
          "Branchi I",
          "Latagliata EC",
          "Pascucci T",
          "Puglisi-Allegra S",
          "Calabresi P",
          "Picconi B"
     ],
     "AD": "Fondazione Santa Lucia, IRCCS, Rome, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy. Section of Behavioural Neurosciences, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita, Rome, Italy. Section of Behavioural Neurosciences, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita, Rome, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy; Dipartimento di Psicologia and Centro \"Daniel Bovet\", Sapienza - Universita di Roma, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy; Dipartimento di Psicologia and Centro \"Daniel Bovet\", Sapienza - Universita di Roma, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy; Dipartimento di Psicologia and Centro \"Daniel Bovet\", Sapienza - Universita di Roma, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy; Clinica Neurologica, Universita degli Studi di Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy. Fondazione Santa Lucia, IRCCS, Rome, Italy. Electronic address: b.picconi@hsantalucia.it.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140721",
     "PL": "United States",
     "TA": "Exp Neurol",
     "JT": "Experimental neurology",
     "JID": "0370712",
     "RN": [
          "0 (Antiparkinson Agents)",
          "0 (Benzazepines)",
          "0 (Dopamine Antagonists)",
          "0 (SCH 23390)",
          "46627O600J (Levodopa)",
          "7MNE9M8287 (Sulpiride)",
          "8HW4YBZ748 (Oxidopamine)",
          "VTD58H1Z2X (Dopamine)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antiparkinson Agents/pharmacology/*therapeutic use",
          "Benzazepines/pharmacology",
          "Dentate Gyrus/*pathology",
          "Disease Models, Animal",
          "Dopamine/metabolism",
          "Dopamine Antagonists/pharmacology",
          "Electric Stimulation",
          "Functional Laterality",
          "Levodopa/pharmacology/*therapeutic use",
          "Long-Term Synaptic Depression/*drug effects",
          "Male",
          "Microdialysis",
          "Norepinephrine/metabolism",
          "Oxidopamine/toxicity",
          "Parkinsonian Disorders/chemically induced/*drug therapy/*pathology",
          "Rats",
          "Rats, Wistar",
          "Sulpiride/pharmacology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Dentate Gyrus",
          "Long-term depression",
          "Parkinson's disease",
          "Synaptic plasticity",
          "Whole-cell patch clamp recordings"
     ],
     "EDAT": "2014/07/25 06:00",
     "MHDA": "2014/12/18 06:00",
     "CRDT": [
          "2014/07/25 06:00"
     ],
     "PHST": [
          "2014/02/26 00:00 [received]",
          "2014/05/30 00:00 [revised]",
          "2014/07/08 00:00 [accepted]",
          "2014/07/25 06:00 [entrez]",
          "2014/07/25 06:00 [pubmed]",
          "2014/12/18 06:00 [medline]"
     ],
     "AID": [
          "S0014-4886(14)00234-9 [pii]",
          "10.1016/j.expneurol.2014.07.006 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Exp Neurol. 2014 Nov;261:377-85. doi: 10.1016/j.expneurol.2014.07.006. Epub 2014 Jul 21.",
     "term": "hippocampus"
}